Mia's Feed
Medical News & Research

New Research Unveils Molecular Signatures Differentiating Depression and Schizophrenia in Blood

New Research Unveils Molecular Signatures Differentiating Depression and Schizophrenia in Blood

Share this article

Scientists have identified specific blood lipid biomarkers that can accurately distinguish between depression and schizophrenia, paving the way for objective mental health diagnostics using blood tests.

2 min read

Recent scientific advancements have demonstrated that blood tests can reliably distinguish between patients with depression and schizophrenia by analyzing specific molecular markers. A team of researchers from Skoltech and other Russian medical institutions analyzed blood plasma samples from over 700 individuals, including healthy controls and patients diagnosed with these psychiatric conditions. Using sophisticated mass spectrometry techniques, they identified 107 lipids with significant alterations across both disorders, with an additional 37 lipids showing disease-specific changes.

These lipid profiles were used to develop machine learning models capable of categorizing patients with an impressive success rate of 83%. This breakthrough signifies a move towards objective, biological diagnostics in mental health, moving beyond traditional symptom-based assessments. The findings suggest that blood lipid analysis could become a powerful tool in early and accurate diagnosis of psychiatric disorders, potentially improving treatment outcomes.

The study highlights that while mental health disorders traditionally rely on subjective evaluation, defining precise biological markers can revolutionize diagnostics and enable personalized medicine approaches. By identifying distinct molecular signatures in blood, clinicians can better differentiate between depression and schizophrenia, aiding in appropriate treatment planning.

Published in the journal Biomolecules, this research marks a significant step forward in psychiatric biomarker discovery. The study's co-authors emphasize that integrating such biological measures into clinical practice could transform mental health diagnosis, providing a reliable and non-invasive tool for healthcare professionals.

Source: https://medicalxpress.com/news/2025-09-distinctive-molecular-footprints-depression-schizophrenia.html

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Bilirubin's Protective Role Against Malaria and Brain Defense

New research uncovers the protective role of bilirubin, a natural pigment, in mitigating severe malaria effects. Elevated bilirubin levels may serve as a natural defense mechanism, opening pathways for innovative therapies.

Impact of Food and Housing Insecurity on Unsafe Gun Storage Practices

Research reveals a strong link between food and housing insecurity and unsafe firearm storage practices, emphasizing the need to address social determinants to improve gun safety and community health.

Primary Care Shortage Impacts Nearly Half of Virginia Neighborhoods, Affecting 3.8 Million Residents

A new study highlights that nearly half of Virginia's neighborhoods lack adequate access to primary care, disproportionately affecting rural communities and impacting 3.8 million residents. Addressing these disparities is essential for improving public health outcomes.

The Rise of the Longevity Industry and Its Hidden Costs

Exploring the rise of the longevity industry and its promising claims about life extension, this article examines the scientific, ethical, and financial risks involved in pursuits of immortality.